Sandbox:Shadan: Difference between revisions

Jump to navigation Jump to search
Line 7: Line 7:


==Classification==
==Classification==
'''Classification of [[breast lumps]] based on [[epithelial hyperplasia]]'''
'''Classification of [[breast lumps]] based on [[epithelial hyperplasia]]<ref name="pmid16034008">{{cite journal| author=Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K et al.| title=Benign breast disease and the risk of breast cancer. | journal=N Engl J Med | year= 2005 | volume= 353 | issue= 3 | pages= 229-37 | pmid=16034008 | doi=10.1056/NEJMoa044383 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16034008  }} </ref>'''
*Approximately 65% of all [[BBD]] considered as [[nonproliferative]](NP)with relative cancer risk of 1.2, 1.4 times:
*Approximately 65% of all [[BBD]] considered as [[nonproliferative]](NP)with relative cancer risk of 1.2, 1.4 times:
**Simple cyst
**Simple cyst
**Fibrosis
**Fibrosis
      *** Fibroadenoma (simple)
*** Fibroadenoma (simple)
    **** Columnar alteration (Simple)
**** Columnar alteration (Simple)
    ***** Apocrine metaplasia (simple)
***** Apocrine metaplasia (simple)
    ****** Mild ductal hyperplasia  
****** Mild ductal hyperplasia  
  ** Approximately 30% of total are classifed as [[proliferative disease(PD) with relative cancer risk of 1.7, 2.1 times
** Approximately 30% of total are classifed as [[proliferative disease(PD) with relative cancer risk of 1.7, 2.1 times
      ** Usual ductal hyperplasia
** Usual ductal hyperplasia
      ***  Sclerosing adenosis
***  Sclerosing adenosis
      **** Columnar hyperplasia  
**** Columnar hyperplasia  
       ***** papilloma
       ***** papilloma
       ****** Radical scar
       ****** Radical scar

Revision as of 16:17, 6 December 2018


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]

Overview

Classification

Classification of breast lumps based on epithelial hyperplasia[1]

  • Approximately 65% of all BBD considered as nonproliferative(NP)with relative cancer risk of 1.2, 1.4 times:
    • Simple cyst
    • Fibrosis
      • Fibroadenoma (simple)
        • Columnar alteration (Simple)
          • Apocrine metaplasia (simple)
            • Mild ductal hyperplasia
    • Approximately 30% of total are classifed as [[proliferative disease(PD) with relative cancer risk of 1.7, 2.1 times
    • Usual ductal hyperplasia
      • Sclerosing adenosis
        • Columnar hyperplasia
      ***** papilloma
      ****** Radical scar
 *** Approximately 5% to 8% of the rest regarded to PD with atypiawith relative cancer risk more than 4 times
     *** Atypical lobar hyperplasia
     **** Lobular carcinoma in situ
     ***** Atypical ductal hyperplasia
**** Unclear risk
     **** Mucocele like tumor
     ***** Apocrine atypia
     ****** Secretory atypia

References

  1. Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K; et al. (2005). "Benign breast disease and the risk of breast cancer". N Engl J Med. 353 (3): 229–37. doi:10.1056/NEJMoa044383. PMID 16034008.